Bunnie XO shares her harrowing experience with an experimental weight-loss drug, describing severe depression and suicidal ...

Precision medicine has transformed the therapeutic landscape by shifting from a "one-size-fits-all" approach to tailored treatments based on individual ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

Joe Ragey didn't think he would live to walk his daughter down the aisle, but thanks to Dr. Kelly Bolton at Washington ...

The U.S. Food and Drug Administration (FDA) has accepted a new drug application for gedatolisib in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA ...

The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...

According to a November poll from the Kaiser Family Foundation, one in eight Americans reported taking a GLP-1 drug, which ...

Walmart this spring will roll out clinical research sites in a limited number of stores and former shuttered clinic sites in ...

Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, ...

This systematic review evaluates preclinical and clinical evidence on glucagon-like peptide-1 receptor agonists as potential ...

FDA requests removal of suicidal ideation warnings from GLP-1 RA labels after meta-analysis shows no increased risk compared with placebo.

January 21, 2026-- Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology th ...